Skip to main content
Top
Published in: Abdominal Radiology 7/2019

01-07-2019 | Hepatobiliary

Assessment of liver T1 mapping in fontan patients and its correlation with magnetic resonance elastography-derived liver stiffness

Authors: Preeti Ramachandran, Suraj D. Serai, Gruschen R. Veldtman, Sean M. Lang, Wojciech Mazur, Andrew T. Trout, Jonathan R. Dillman, Robert J. Fleck, Michael D. Taylor, Tarek Alsaied, Ryan A. Moore

Published in: Abdominal Radiology | Issue 7/2019

Login to get access

Abstract

Objectives

To explore the utility of liver T1 mapping in Fontan patients and its correlation to magnetic resonance elastography (MRE)-derived liver stiffness.

Background and aims

Liver disease is a major long-term extra cardiac complication in the Fontan population. MRE is frequently used to quantify liver stiffness in Fontan patients; however, it has certain limitations. Native T1 mapping by cardiac magnetic resonance (CMR) is useful in assessment of cardiac fibrosis, but its potential in evaluating liver fibrosis and its correlation to MRE-derived liver stiffness in Fontan patients have not been reported.

Methods

Fontan patients who underwent CMR and MRE were included. Liver Native T1, extracellular volume (ECV) and delta coefficients were measured and correlated with MRE-derived liver stiffness in all Fontan patients. Native liver T1 in Fontan patients were compared to normal controls with biventricular circulation and no known liver disease.

Results

A total of 17 Fontan patients and 7 normal controls were included in this study. Fontan patients had significantly higher liver native T1 (690 ± 41 ms vs 620 ± 35 ms; p < 0.001) as compared to controls. There was strong positive correlation between MRE derived liver stiffness and liver native T1 (r = 0.81, p < 0.001).

Conclusions

Liver native T1 was significantly elevated in Fontan patients compared to controls and strongly correlated with MRE-derived liver stiffness. This technique may prove to be a useful noninvasive imaging biomarker for assessing liver fibrosis in the Fontan population.
Literature
1.
go back to reference Daniels CJ, Bradley EA, Landzberg MJ, et al. Fontan-Associated Liver Disease: Proceedings from the American College of Cardiology Stakeholders Meeting, October 1 to 2, 2015, Washington DC. Journal of the American College of Cardiology. 2017;70(25):3173-94.CrossRefPubMed Daniels CJ, Bradley EA, Landzberg MJ, et al. Fontan-Associated Liver Disease: Proceedings from the American College of Cardiology Stakeholders Meeting, October 1 to 2, 2015, Washington DC. Journal of the American College of Cardiology. 2017;70(25):3173-94.CrossRefPubMed
2.
go back to reference van Nieuwenhuizen RC, Peters M, Lubbers LJ, Trip MD, Tijssen JG, Mulder BJ. Abnormalities in liver function and coagulation profile following the Fontan procedure. Heart (British Cardiac Society). 1999;82(1):40-6. van Nieuwenhuizen RC, Peters M, Lubbers LJ, Trip MD, Tijssen JG, Mulder BJ. Abnormalities in liver function and coagulation profile following the Fontan procedure. Heart (British Cardiac Society). 1999;82(1):40-6.
3.
go back to reference Rychik J, Veldtman G, Rand E, et al. The precarious state of the liver after a Fontan operation: summary of a multidisciplinary symposium. Pediatric cardiology. 2012;33(7):1001-12.CrossRefPubMedPubMedCentral Rychik J, Veldtman G, Rand E, et al. The precarious state of the liver after a Fontan operation: summary of a multidisciplinary symposium. Pediatric cardiology. 2012;33(7):1001-12.CrossRefPubMedPubMedCentral
4.
go back to reference Greenway SC, Crossland DS, Hudson M, et al. Fontan-associated liver disease: Implications for heart transplantation. J Heart Lung Transplant. 2016;35(1):26-33.CrossRefPubMed Greenway SC, Crossland DS, Hudson M, et al. Fontan-associated liver disease: Implications for heart transplantation. J Heart Lung Transplant. 2016;35(1):26-33.CrossRefPubMed
5.
go back to reference Guha IN, Bokhandi S, Ahmad Z, et al. Structural and functional uncoupling of liver performance in the Fontan circulation. International journal of cardiology. 2013;164(1):77-81.CrossRefPubMed Guha IN, Bokhandi S, Ahmad Z, et al. Structural and functional uncoupling of liver performance in the Fontan circulation. International journal of cardiology. 2013;164(1):77-81.CrossRefPubMed
6.
go back to reference Tomita H, Yamada O, Ohuchi H, et al. Coagulation profile, hepatic function, and hemodynamics following Fontan-type operations. Cardiology in the young. 2001;11(1):62-6.CrossRefPubMed Tomita H, Yamada O, Ohuchi H, et al. Coagulation profile, hepatic function, and hemodynamics following Fontan-type operations. Cardiology in the young. 2001;11(1):62-6.CrossRefPubMed
7.
go back to reference Fidai A, Dallaire F, Alvarez N, et al. Non-invasive Investigations for the Diagnosis of Fontan-Associated Liver Disease in Pediatric and Adult Fontan Patients. Front Cardiovasc Med. 2017;4:15.CrossRefPubMedPubMedCentral Fidai A, Dallaire F, Alvarez N, et al. Non-invasive Investigations for the Diagnosis of Fontan-Associated Liver Disease in Pediatric and Adult Fontan Patients. Front Cardiovasc Med. 2017;4:15.CrossRefPubMedPubMedCentral
8.
go back to reference Ghaferi AA, Hutchins GM. Progression of liver pathology in patients undergoing the Fontan procedure: Chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma. The Journal of thoracic and cardiovascular surgery. 2005;129(6):1348-52.CrossRefPubMed Ghaferi AA, Hutchins GM. Progression of liver pathology in patients undergoing the Fontan procedure: Chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma. The Journal of thoracic and cardiovascular surgery. 2005;129(6):1348-52.CrossRefPubMed
9.
go back to reference Bryant T, Ahmad Z, Millward-Sadler H, et al. Arterialised hepatic nodules in the Fontan circulation: hepatico-cardiac interactions. International journal of cardiology. 2011;151(3):268-72.CrossRefPubMed Bryant T, Ahmad Z, Millward-Sadler H, et al. Arterialised hepatic nodules in the Fontan circulation: hepatico-cardiac interactions. International journal of cardiology. 2011;151(3):268-72.CrossRefPubMed
10.
go back to reference Elder RW, McCabe NM, Hebson C, et al. Features of portal hypertension are associated with major adverse events in Fontan patients: the VAST study. International journal of cardiology. 2013;168(4):3764-9.CrossRefPubMedPubMedCentral Elder RW, McCabe NM, Hebson C, et al. Features of portal hypertension are associated with major adverse events in Fontan patients: the VAST study. International journal of cardiology. 2013;168(4):3764-9.CrossRefPubMedPubMedCentral
11.
go back to reference Assenza GE, Graham DA, Landzberg MJ, et al. MELD-XI score and cardiac mortality or transplantation in patients after Fontan surgery. Heart (British Cardiac Society). 2013;99(7):491-6. Assenza GE, Graham DA, Landzberg MJ, et al. MELD-XI score and cardiac mortality or transplantation in patients after Fontan surgery. Heart (British Cardiac Society). 2013;99(7):491-6.
12.
go back to reference Cromme-Dijkhuis AH, Hess J, Hahlen K, et al. Specific sequelae after Fontan operation at mid- and long-term follow-up. Arrhythmia, liver dysfunction, and coagulation disorders. The Journal of thoracic and cardiovascular surgery. 1993;106(6):1126-32. Cromme-Dijkhuis AH, Hess J, Hahlen K, et al. Specific sequelae after Fontan operation at mid- and long-term follow-up. Arrhythmia, liver dysfunction, and coagulation disorders. The Journal of thoracic and cardiovascular surgery. 1993;106(6):1126-32.
13.
go back to reference Goldberg DJ, Surrey LF, Glatz AC, et al. Hepatic Fibrosis Is Universal Following Fontan Operation, and Severity is Associated With Time From Surgery: A Liver Biopsy and Hemodynamic Study. Journal of the American Heart Association. 2017;6(5). Goldberg DJ, Surrey LF, Glatz AC, et al. Hepatic Fibrosis Is Universal Following Fontan Operation, and Severity is Associated With Time From Surgery: A Liver Biopsy and Hemodynamic Study. Journal of the American Heart Association. 2017;6(5).
14.
go back to reference Wallihan DB, Podberesky DJ, Marino BS, Sticka JS, Serai S. Relationship of MR elastography determined liver stiffness with cardiac function after Fontan palliation. Journal of magnetic resonance imaging : JMRI. 2014;40(6):1328-35.CrossRefPubMed Wallihan DB, Podberesky DJ, Marino BS, Sticka JS, Serai S. Relationship of MR elastography determined liver stiffness with cardiac function after Fontan palliation. Journal of magnetic resonance imaging : JMRI. 2014;40(6):1328-35.CrossRefPubMed
15.
go back to reference Xanthakos SA, Podberesky DJ, Serai SD, et al. Use of magnetic resonance elastography to assess hepatic fibrosis in children with chronic liver disease. The Journal of pediatrics. 2014;164(1):186-8.CrossRefPubMed Xanthakos SA, Podberesky DJ, Serai SD, et al. Use of magnetic resonance elastography to assess hepatic fibrosis in children with chronic liver disease. The Journal of pediatrics. 2014;164(1):186-8.CrossRefPubMed
16.
go back to reference Banerjee R, Pavlides M, Tunnicliffe EM, et al. Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease. Journal of hepatology. 2014;60(1):69-77.CrossRefPubMedPubMedCentral Banerjee R, Pavlides M, Tunnicliffe EM, et al. Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease. Journal of hepatology. 2014;60(1):69-77.CrossRefPubMedPubMedCentral
17.
go back to reference Zeng M, Zhang N, He Y, et al. Histological validation of cardiac magnetic resonance T1 mapping for detecting diffuse myocardial fibrosis in diabetic rabbits. Journal of magnetic resonance imaging : JMRI. 2016;44(5):1179-85.CrossRefPubMed Zeng M, Zhang N, He Y, et al. Histological validation of cardiac magnetic resonance T1 mapping for detecting diffuse myocardial fibrosis in diabetic rabbits. Journal of magnetic resonance imaging : JMRI. 2016;44(5):1179-85.CrossRefPubMed
18.
go back to reference Sheng RF, Wang HQ, Yang L, et al. Assessment of liver fibrosis using T1 mapping on Gd-EOB-DTPA-enhanced magnetic resonance. Dig Liver Dis. 2017;49(7):789-95.CrossRefPubMed Sheng RF, Wang HQ, Yang L, et al. Assessment of liver fibrosis using T1 mapping on Gd-EOB-DTPA-enhanced magnetic resonance. Dig Liver Dis. 2017;49(7):789-95.CrossRefPubMed
19.
go back to reference Yoon JH, Lee JM, Paek M, Han JK, Choi BI. Quantitative assessment of hepatic function: modified look-locker inversion recovery (MOLLI) sequence for T1 mapping on Gd-EOB-DTPA-enhanced liver MR imaging. Eur Radiol. 2016;26(6):1775-82.CrossRefPubMed Yoon JH, Lee JM, Paek M, Han JK, Choi BI. Quantitative assessment of hepatic function: modified look-locker inversion recovery (MOLLI) sequence for T1 mapping on Gd-EOB-DTPA-enhanced liver MR imaging. Eur Radiol. 2016;26(6):1775-82.CrossRefPubMed
20.
go back to reference Haimerl M, Verloh N, Zeman F, et al. Assessment of clinical signs of liver cirrhosis using T1 mapping on Gd-EOB-DTPA-enhanced 3T MRI. PLoS One. 2013;8(12):e85658.CrossRefPubMedPubMedCentral Haimerl M, Verloh N, Zeman F, et al. Assessment of clinical signs of liver cirrhosis using T1 mapping on Gd-EOB-DTPA-enhanced 3T MRI. PLoS One. 2013;8(12):e85658.CrossRefPubMedPubMedCentral
21.
go back to reference Messroghli DR, Greiser A, Frohlich M, Dietz R, Schulz-Menger J. Optimization and validation of a fully-integrated pulse sequence for modified look-locker inversion-recovery (MOLLI) T1 mapping of the heart. Journal of magnetic resonance imaging : JMRI. 2007;26(4):1081-6.CrossRefPubMed Messroghli DR, Greiser A, Frohlich M, Dietz R, Schulz-Menger J. Optimization and validation of a fully-integrated pulse sequence for modified look-locker inversion-recovery (MOLLI) T1 mapping of the heart. Journal of magnetic resonance imaging : JMRI. 2007;26(4):1081-6.CrossRefPubMed
22.
go back to reference Messroghli DR, Radjenovic A, Kozerke S, Higgins DM, Sivananthan MU, Ridgway JP. Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med. 2004;52(1):141-6.CrossRefPubMed Messroghli DR, Radjenovic A, Kozerke S, Higgins DM, Sivananthan MU, Ridgway JP. Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med. 2004;52(1):141-6.CrossRefPubMed
23.
go back to reference Serai SD, Wallihan DB, Venkatesh SK, et al. Magnetic resonance elastography of the liver in patients status-post fontan procedure: feasibility and preliminary results. Congenital heart disease. 2014;9(1):7-14.CrossRefPubMed Serai SD, Wallihan DB, Venkatesh SK, et al. Magnetic resonance elastography of the liver in patients status-post fontan procedure: feasibility and preliminary results. Congenital heart disease. 2014;9(1):7-14.CrossRefPubMed
24.
go back to reference Poterucha JT, Johnson JN, Qureshi MY, et al. Magnetic Resonance Elastography: A Novel Technique for the Detection of Hepatic Fibrosis and Hepatocellular Carcinoma After the Fontan Operation. Mayo Clin Proc. 2015;90(7):882-94.CrossRefPubMedPubMedCentral Poterucha JT, Johnson JN, Qureshi MY, et al. Magnetic Resonance Elastography: A Novel Technique for the Detection of Hepatic Fibrosis and Hepatocellular Carcinoma After the Fontan Operation. Mayo Clin Proc. 2015;90(7):882-94.CrossRefPubMedPubMedCentral
25.
go back to reference Serai SD, Trout AT, Miethke A, Diaz E, Xanthakos SA, Dillman JR. Putting it all together: established and emerging MRI techniques for detecting and measuring liver fibrosis. Pediatric radiology. 2018;48(9):1256-72.CrossRefPubMed Serai SD, Trout AT, Miethke A, Diaz E, Xanthakos SA, Dillman JR. Putting it all together: established and emerging MRI techniques for detecting and measuring liver fibrosis. Pediatric radiology. 2018;48(9):1256-72.CrossRefPubMed
26.
go back to reference Serai SD, Trout AT, Sirlin CB. Elastography to assess the stage of liver fibrosis in children: Concepts, opportunities, and challenges. Clinical Liver Disease. 2017;9(1):5-10.CrossRefPubMedPubMedCentral Serai SD, Trout AT, Sirlin CB. Elastography to assess the stage of liver fibrosis in children: Concepts, opportunities, and challenges. Clinical Liver Disease. 2017;9(1):5-10.CrossRefPubMedPubMedCentral
27.
go back to reference Serai SD, Towbin AJ, Podberesky DJ. Pediatric liver MR elastography. Digestive diseases and sciences. 2012;57(10):2713-9.CrossRefPubMed Serai SD, Towbin AJ, Podberesky DJ. Pediatric liver MR elastography. Digestive diseases and sciences. 2012;57(10):2713-9.CrossRefPubMed
28.
go back to reference Messroghli DR, Moon JC, Ferreira VM, et al. Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI). Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance. 2017;19(1):75.CrossRef Messroghli DR, Moon JC, Ferreira VM, et al. Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI). Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance. 2017;19(1):75.CrossRef
29.
go back to reference Moon JC, Messroghli DR, Kellman P, et al. Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance. 2013;15:92.CrossRef Moon JC, Messroghli DR, Kellman P, et al. Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance. 2013;15:92.CrossRef
30.
go back to reference Li Z, Sun J, Hu X, et al. Assessment of liver fibrosis by variable flip angle T1 mapping at 3.0T. Journal of magnetic resonance imaging : JMRI. 2016;43(3):698-703. Li Z, Sun J, Hu X, et al. Assessment of liver fibrosis by variable flip angle T1 mapping at 3.0T. Journal of magnetic resonance imaging : JMRI. 2016;43(3):698-703.
31.
go back to reference Kutty SS, Zhang M, Danford DA, et al. Hepatic stiffness in the bidirectional cavopulmonary circulation: The Liver Adult-Pediatric-Congenital-Heart-Disease Dysfunction Study group. The Journal of thoracic and cardiovascular surgery. 2016;151(3):678-84.CrossRefPubMed Kutty SS, Zhang M, Danford DA, et al. Hepatic stiffness in the bidirectional cavopulmonary circulation: The Liver Adult-Pediatric-Congenital-Heart-Disease Dysfunction Study group. The Journal of thoracic and cardiovascular surgery. 2016;151(3):678-84.CrossRefPubMed
Metadata
Title
Assessment of liver T1 mapping in fontan patients and its correlation with magnetic resonance elastography-derived liver stiffness
Authors
Preeti Ramachandran
Suraj D. Serai
Gruschen R. Veldtman
Sean M. Lang
Wojciech Mazur
Andrew T. Trout
Jonathan R. Dillman
Robert J. Fleck
Michael D. Taylor
Tarek Alsaied
Ryan A. Moore
Publication date
01-07-2019
Publisher
Springer US
Published in
Abdominal Radiology / Issue 7/2019
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-019-01990-9

Other articles of this Issue 7/2019

Abdominal Radiology 7/2019 Go to the issue

Classics in Abdominal Radiology

Bare area sign

Classics in Abdominal Radiology

The stalk-of-corn sign of ureter

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.